Adverum Biotechnologies, Inc. Public Float
Adverum Biotechnologies, Inc. had Public Float of $136.70 million as of 2024-06-30, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2025-04-15
- 2024-06-30: Entity Public Float $136.70M.
- 2023-06-30: Entity Public Float $151.80M.
- 2022-06-30: Entity Public Float $114.90M.
- 2021-06-30: Entity Public Float $320.30M.
| Period end | Entity Public Float |
|---|---|
| 2024-06-30 | $136.70M 10-K · filed 2025-04-15 |
| 2023-06-30 | $151.80M 10-K · filed 2024-03-18 |
| 2022-06-30 | $114.90M 10-K · filed 2023-03-30 |
| 2021-06-30 | $320.30M 10-K · filed 2022-03-29 |
| 2020-06-30 | $1.50B 10-K · filed 2021-03-01 |
| 2019-06-30 | $674.50M 10-K · filed 2020-03-12 |
| 2018-06-30 | $294.80M 10-K · filed 2019-03-06 |
| 2017-06-30 | $87.80M 10-K · filed 2018-03-06 |
| 2016-06-30 | $99.80M 10-K · filed 2017-03-09 |
| 2015-06-30 | $328.50M 10-K · filed 2016-03-04 |
| 2014-06-30 | $0.00 10-K · filed 2015-03-05 |